Resistance	Microbe	Outcome
Enrofloxacin /	Campylobacter coli	See: Table 4 AMR+ (n) AMR- (n) Total (n) Aminoglycoside use 5 0 5 No use 54 96 150
Erythromycin /	Campylobacter coli	See: Table 4 AMR+ (n) AMR- (n) Total (n) Aminoglycoside use 4 1 5 No use 72 78 150
Chloramphenicol /	Campylobacter coli	See: Table 4 AMR+ (n) AMR- (n) Total (n) Aminoglycoside use 1 4 5 No use 50 100 150